2021
DOI: 10.1016/j.jics.2021.100041
|View full text |Cite
|
Sign up to set email alerts
|

A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 42 publications
0
11
0
Order By: Relevance
“…The binding energy, number of hydrogen bond interactions, inhibition constant and interacting amino acid residues were summarized in Table 5 . The binding energy of the synthesized chalcone compound EBDN is −7.25 Kcal/mol [39] , [40] , [41] , [42] , [43] , [44] , [45] . The EBDN has shown strong four hydrogen bond (H-bond) interaction with targeted SARS-CoV-2 main protease (6yb7).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The binding energy, number of hydrogen bond interactions, inhibition constant and interacting amino acid residues were summarized in Table 5 . The binding energy of the synthesized chalcone compound EBDN is −7.25 Kcal/mol [39] , [40] , [41] , [42] , [43] , [44] , [45] . The EBDN has shown strong four hydrogen bond (H-bond) interaction with targeted SARS-CoV-2 main protease (6yb7).…”
Section: Resultsmentioning
confidence: 99%
“…Since it's unveiling at the end of December 2019, SARS-CoV-2 has remained to spread chop-chop throughout the world. Despite the fact that the number of deaths caused by COVID-19 is rapidly increasing, an effective drug treatment other than vaccines has yet to be developed.The existing literature comprises many investigations on SARS-CoV-2 main protease and its potential inhibitors [39] , [40] , [41] , [42] , [43] , [44] , [45] .…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, several in silico molecular modelling and preclinical studies have also suggested the plausibility of the above mentioned antiviral compounds to control and prevent the replication and transcription of SARS-CoV-2 [35] . However, those studies have reported different compounds as the top ranked compounds against RdRp [21] , [36] , [37] , [38] . Identifying potential drug candidates that have promising clinical efficacy to combat and cure the disease is the highest priority to keep this public health threat at bay.…”
Section: Introductionmentioning
confidence: 99%
“…ESTROGEN ALPHA RECEPTOR [12], ALPHA GLUCOSIDASE [13], HMG COA [14], 5COX [15], SAR COV-2 [16] using an In silico molecular docking analysis with AutoDock Vina software and also an investigation on the enzymes binding sites using Discovery Studio Version 3.5.…”
Section: Introductionmentioning
confidence: 99%